Welcome to Nigeria Clinical Trials Registry

You will need to Register as a Nurse or Consultant before you are allowed access. If you are already registered, simply login with your email address and your password

Member Login

Don't Have Account? Click here to create one

Password Reset Request

Enter your email Address to get a new password!

Nigeria Clinical Trials Registry

NigeriaClinical Trials Registry

Because of ethical and scientific reasons, NCTR is established for registering trials. There will be Open access to information about ongoing and completed trials

Learn More

Quick Info!

For Patients & Families

For Researchers


View Edit Public Title Trial ID Status Date of registration
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11
View Edit A Phase 2 Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of rVSV60- LASV-GPC Vaccine in Adults and Children 0 Pending 2023-04-11

Subscribe to Our Newsletter

About NCTR?

NCTR Initiative

The NCTR is a collaborative initiative of the National Agency for Food & Drugs Administration and Control, with support from the National Health Research Ethics Committee and the Federal Ministry of Health

Contact Us

Address: Federal Ministry of Health, Federal Secretariat Complex Shehu Shagari Way, Garki, Abuja
Email: info@nhrec.net